Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX)
0.7562
-0.0632 (-7.71%)
Lexicon Pharmaceuticals is a biopharmaceutical company that focuses on the development of innovative therapies to treat various diseases, including rare genetic disorders and chronic conditions
Through its cutting-edge research and development initiatives, Lexicon aims to leverage its proprietary drug discovery platform to identify and advance new treatment options that can significantly improve patient outcomes. The company is committed to making a positive impact on healthcare by addressing unmet medical needs through its portfolio of potential therapeutic candidates.
Frequently Asked Questions
Is Lexicon Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Lexicon Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Lexicon Pharmaceuticals, Inc. - Common Stock trade on?
Lexicon Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexicon Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Lexicon Pharmaceuticals, Inc. - Common Stock is LXRX on the Nasdaq Stock Market
What is the current price of Lexicon Pharmaceuticals, Inc. - Common Stock?
The current price of Lexicon Pharmaceuticals, Inc. - Common Stock is 0.7562
When was Lexicon Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Lexicon Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Lexicon Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Lexicon Pharmaceuticals, Inc. - Common Stock is 109.25M
How many shares of Lexicon Pharmaceuticals, Inc. - Common Stock are outstanding?
Lexicon Pharmaceuticals, Inc. - Common Stock has 144.47M shares outstanding.